Latest Articles
AI imaging technique detects early endometrial cancer with high accuracy - News-Medical
AI imaging technique detects early endometrial cancer with high accuracy News-Medical
Published: June 19, 2026, 2:55 a.m.
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise - Newswise
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise Newswise
Published: June 18, 2026, 11:20 p.m.
Quick optical biopsy could be early detection method for endometrial cancer | Newswise - Newswise
Quick optical biopsy could be early detection method for endometrial cancer | Newswise Newswise
Published: June 18, 2026, 8:15 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter
Published: June 18, 2026, 2:24 p.m.
Common symptom was terminal cancer - Geelong Advertiser
Common symptom was terminal cancer Geelong Advertiser
Published: June 18, 2026, 2:11 p.m.
Mum’s common symptom was terminal cancer - News.com.au
Mum’s common symptom was terminal cancer News.com.au
Published: June 18, 2026, 1:44 p.m.
Common symptom was terminal cancer - The Chronicle | The Chronicle
Common symptom was terminal cancer The Chronicle | The Chronicle
Published: June 18, 2026, 12:30 p.m.
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia - Vera Health
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia Vera Health
Published: June 18, 2026, 12:22 p.m.
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer OncLive
Published: June 17, 2026, 9:31 p.m.
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer - OncLive
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer OncLive
Published: June 17, 2026, 9:11 p.m.
Link copied to clipboard!